Bill

Bill > HB679


MD HB679

MD HB679
Health Occupations - Cross-Sex Hormone Therapy for Minors


summary

Introduced
02/02/2026
In Committee
02/02/2026
Crossed Over
Passed
Dead

Introduced Session

2026 Regular Session

Bill Summary

Prohibiting a licensed health care practitioner from prescribing, dispensing, or administering a cross-sex hormone or otherwise providing cross-sex hormone therapy for the treatment of a mental health diagnoses associated with gender nonconformity, including gender dysphoria, to an individual who is a minor.

AI Summary

This bill prohibits licensed healthcare practitioners in Maryland from prescribing, dispensing, or administering "cross-sex hormones" (which are defined as prescription hormones like estrogen and testosterone, or hormone blockers like testosterone blockers) or providing "cross-sex hormone therapy" (defined as treatment to develop secondary sex characteristics for someone transitioning from their sex assigned at birth to their experienced or expressed gender) to individuals under the age of 18 for the purpose of treating mental health diagnoses associated with gender nonconformity, including gender dysphoria. Violating this provision would be a felony punishable by imprisonment up to life, and the Department of Health is authorized to adopt regulations to implement this section, which is set to take effect on October 1, 2026.

Committee Categories

Health and Social Services

Sponsors (12)

Last Action

House Health Hearing (13:30:00 2/18/2026 ) (on 02/18/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...